Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 462 participants.
Also called NCT05892510
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 462 participants
- Sponsor
- Registry
-
NCT05892510
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Australia, New Zealand
- Registry status
- Recruiting
Technical summary
Registry record NCT05892510. Randomized; quadruple masking; primary purpose treatment. Start 2024-06-01 (actual); primary completion 2027-08-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
- Condition
- Ischemic Stroke, Acute
- Condition
- Cerebrovascular Disorders
- Condition
- Brain Disorder
- Condition
- Central Nervous System Diseases
- Intervention (Drug)
- Intra-arterial tenecteplase injection at the completion of thrombectomy
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Melbourne
Record details
- Record id
cardio:ct-nct05892510- Content hash
5df5f2b1b53032cd544395e8dfd464313316a4b62fc4c582f5aefdc478494022